鞘脂
鞘糖脂
酶
化学
神经酰胺
生物化学
细胞生物学
标识
DOI:10.1016/j.chemphyslip.2011.04.013
摘要
Sphingolipid and glycosphingolipid levels and expression of sphingolipid metabolizing enzymes are altered in a variety of diseases or in response to drug treatment. Inherited defects of enzymes and other proteins required for the lysosomal degradation of these lipids lead to human sphingolipidoses. Also genetic defects that affect sphingolipid biosynthesis are known. Although the molecular details are often far from clear, (glyco)sphingolipids have been implicated to play a role in atherosclerosis, insulin resistance, cancer, and infections by pathogens. More general aspects of selected diseases are discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI